Novartis/Alcon After assessing strategic options for Alcon, Novartis is spin-ning it out to shareholders. As a result, both companies will now rivet on their core strengths –pharmaceuticals and oph-thalmic devices, respectively. When Novartis acquired Alcon in 2011 for $52b, the business included surgical, vision care and ophthalmic pharmaceuticals. In 2016, Novartis absorbed Alcon’s drug business, leaving Alcon as pure …
Sivantos and Widex Announce Merger
Sivantos, a Germany-based hearing aid maker previously owned by Siemens will merge with Widex, a Denmark-based hearing aid maker to form a company with an enterprise value of more than $8b. Sivantos, owned by EQT Partners, and Widex are merging to form the 3rd largest hearing aid maker. The merger will likely push back EQT’s plans for an IPO of Sivantos by a few years, …
As part of J&J’s de-diversifying, it is selling its Advanced Sterilization Products (ASP) business to Fortive Corportion (a Danaher spinout)
Fortive Corporation, a $6.86b diversified conglomerate spinout from Danaher, is acquiring Johnson & Johnson’s Advanced Sterilization Products (ASP) business for $2.8b. ASP provides sterilization and disinfection systems and low-temperature hydrogen peroxide sterilization technology. ASP’s products include the STERRAD system for sterilizing instruments, EVOTECH and ENDOCLENS systems for endoscope reprocessing and cleaning. JNJ sold approximately $2.1b of both units. Last year, JNJ acquired Actelion for …
Boston Scientific Announces Acquisition Of nVision Medical Corporation
Boston Scientific Corporation, a $8.83b manufacturer of medical devices for cardiovascular, digestive, pulmonary and other interventional specialties is acquiring nVision Medical, a developer of a device for collecting cells from the fallopian tubes to detect ovarian cancer. Ovarian cancer is the fifth leading cause of cancer death among women. More than 2 million women in the U.S. are at high risk and it …
Johnson & Johnson Acquired Orthotaxy to Develop a Robotic-Assisted Orthopedic Surgery Solution
With its acquisition of Orthotaxy, Johnson & Johnson joins a growing list of medtech players strengthening surgical robotics offerings expanding the technology’s applications. Orthotaxy’s is in early-stage development for total and partial knee replacement. The deal helps J&J compete more effectively against Stryker’s Mako orthopedic surgical solution, acquired in 2013. In 2015, J&J’s Ethicon unit partnered with Verily, Google’s life sciences unit, to form Verb, …
Roche acquires Flatiron Health for $1.9b
Roche Holding AG, a $54.1b research-focused, biotechnology company is acquiring Flatiron Health, a developer of an OncologyCloud platform which includes medical record for oncology, advanced analytics, patient portal and integrated billing for $1.9b. Flatiron’s cancer-centric electronic health records platform is connected to about 250 community oncology practices; it has a partnership with the National Cancer Institute (NCI), a part of the National Institutes …
Allergan to Acquire Elastagen’s Next Generation Injectable Portfolio for $95m
Allergan Plc, a $15.9b provider of medical aesthetics, biosimilars, and over-the-counter pharmaceutical products will acquire Elastagen Pty Ltd., a provider of advanced tissue repair platform based on tropoelastin (gives tissue its elasticity) for $95m. The acquisition adds proprietary injectable products to Allergan’s existing portfolio. Elastagen’s technology is based on human tropoelastin, the precursor of elastin which is a key component of youthful skin. …
Boston Scientific Corporation acquires Millipede, Inc. for $90m
Boston Scientific Corporation, a $8.83b manufacturer of medical devices for cardiovascular, digestive, pulmonary and other interventional specialties is acquiring Millipede, Inc., a developer of transcatheter, semi-rigid, complete annuloplasty ring for the treatment of heart disease for $90m. Millipede IRIS’ annuloplasty ring which is delivered via a transcatheter-transseptal delivery system repairs and reduce the size of a dilated mitral annulus. The IRIS device is a …
Wright Medical Group N.V acquires Imascap SAS
Wright Medical Group N.V, a $720.4m developer of specialty orthopedics focused on extremity and biologic solutions is acquiring Imascap SAS, a developer preoperative planning of shoulder replacement surgery software for $62.50m plus $26.30m in milestones. The deal accelerates Wright Medical’s product portfolio and leverages its extremities business. IMASCAP’s Glenosys technology allows surgeon to simulate the position of a shoulder prosthesis using CT image …
Three Important Healthcare Services M&A Deals
CVS Health Corporation to acquire Aetna for $69b CVS Health Corporation, a $180.7b retail pharmacy and health care company has agreed to buy Aetna, a $61.4b managed health care company, which sells traditional and consumer directed health care insurance plans and related services for $69b. The combination creates a comprehensive health-care platform for consumers by offering a community-based health hub …